Evidence map›Paper›PMID 39038269›Full record

ReviewBrazilian journal of cardiovascular surgery2024

Cardiac Tumors: Review.

Carlos J T Karigyo, Beatriz Mella S Pessoa, Samuel Pissinati Nicacio, Emma Terwilliger, Philippos Costa, Pedro Reck Dos Santos, Vinicius Ernani, Mahesh Seetharam, Alexandre Noburu Murakami, Felipe Batalini

Abstract readReview
In one paragraph

Review in Brazilian journal of cardiovascular surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Cardiac Tumors Revisited.Brazilian journal of cardiovascular surgery · 2025
    Article
  10. Article
  11. A Young Man With Primary Pulmonary Myxoma.Clinical case reports · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Carlos J T KarigyoEngineering Center for Circulatory Assistance, Instituto Dante Pazzanese de Cardiologia, São Paulo, São Paulo, Brazil.ORCID 0000-0002-3579-0781
Beatriz Mella S PessoaFaculdade de Medicina, Universidade Federal do Amazonas, Manaus, Amazonas, Brazil.
Samuel Pissinati NicacioFaculdade de Medicina, Universidade Estadual de Londrina, Londrina, Paraná, Brazil.
Emma TerwilligerMayo Clinic College of Medicine and Science, Rochester, Minnesota, United States of America.
Philippos CostaDivision of Hematology and Oncology, Yale University Yale Cancer Center, New Haven, Connecticut, United States of America.
Pedro Reck Dos SantosDivision of Cardiothoracic Surgery, Mayo Clinic Arizona, Phoenix, Arizona, United States of America.
Vinicius ErnaniDivision of Oncology, Mayo Clinic Arizona, Phoenix, Arizona, United States of America.
Mahesh SeetharamDivision of Oncology, Mayo Clinic Arizona, Phoenix, Arizona, United States of America.
Alexandre Noburu MurakamiDivision of Cardiac Surgery, Universidade Estadual de Londrina, Londrina, Paraná, Brazil.
Felipe BataliniMayo Clinic Arizona Division of Oncology Phoenix Arizona United States of America Division of Oncology, Mayo Clinic Arizona, Phoenix, Arizona, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac tumors are rare and encompass a variety of presentations. Clinica symptoms are usually nonspecific, but they can present as obstructive, embolic, or constitutional symptoms. Treatment options and prognosis vary highly depending on the subtype, tumor size, and location. Surgical resection is usually the first-line therapy, except for cardiac lymphomas, and provides favorable long-term prognosis in most benign tumors. Cardiac sarcomas, however, are usually diagnosed in advanced stages, and the treatment relies on a multimodal approach with chemotherapy and radiotherapy. Metastatic cardiac tumors are usually related to advanced disease and carry an overall poor prognosis.

Indexed as

Heart NeoplasmsSarcomaHumansPrognosisHeart Neo plasmsLymphomaPrognosisSarcoma

Identifiers

PMID39038269
PMCPMC11262154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.